Delivery Order SPE2DR25D2005-SPE2DR26FE6D0
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,278.36 to AmerisourceBergen Drug Corp for Shingrix vial kits on July 16, 2025, with completion targeted for July 17, 2025. This competitively awarded, firm fixed price delivery order represents a small-value pharmaceutical procurement executed through AmerisourceBergen's existing contract vehicle with DLA. The work will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. Shingrix is a recombinant...
- The Defense Logistics Agency awarded a $14,012.49 delivery order to AmerisourceBergen Drug Corp for Shingrix vial kits, with an ultimate completion date of August 18, 2025. This contract represents a firm fixed-price delivery order issued under a competitive procurement with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Shingrix is a recombinant zoster vaccine used for the prevention of herpes zoster (shingles) in...
- The Defense Logistics Agency awarded a $15,032.22 delivery order to AmerisourceBergen Drug Corp for Shingrix vial kits, with an ultimate completion date of April 25, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The place of performance is listed as Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $11,391.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Shingrix vial kits, with a completion date of June 6, 2025. This non-set-aside contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion vehicle designated SPE2DX and running through December 2026. The order will be fulfilled from AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $4,962.90 to AmerisourceBergen Drug Corp for Shingrix vial kits on November 5, 2025, with completion expected by November 6, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Shingrix is a recombinant zoster vaccine used for the prevention of herpes zoster (shingles) and is a...
- The Defense Logistics Agency awarded a $7,870.84 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Shingrix vial kits with an ultimate completion date of October 31, 2025. This non-set-aside contract was competitively awarded and represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement extending through December 2026. Shingrix is a recombinant zoster...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Shingrix vial kits with a ceiling value of $1,139.18. This firm fixed-price contract, which was competitively awarded without a set-aside designation, has an ultimate completion date of August 5, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Shingrix is a recombinant zoster vaccine commonly procured for military and veteran healthcare systems to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Shingrix vial kits valued at $8,769.12, with an ultimate completion date of August 15, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a $11,391.80 firm fixed price delivery order to AmerisourceBergen Drug Corp for Shingrix vial kits, with an ultimate completion date of June 3, 2025. This is a non-set-aside competitive award issued on June 2, 2025, with performance to occur at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Shingrix is a recombinant zoster vaccine indicated for the prevention of herpes zoster and its complications in older adults and immunocompromised...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Shingrix vial kits, valued at $1,139.18, with an ultimate completion date of May 13, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Shingrix is a recombinant zoster vaccine indicated for the prevention of herpes zoster and its complications in adults, making this...
- SPE2DR25D2005Indefinite Delivery Contract
- SPE2DR25D2005-SPE2DR26FE6D0Delivery Order
The Defense Logistics Agency awarded a $1,102.87 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Shingrix vial kits, with completion scheduled for November 5, 2025. This non-set-aside contract was competitively awarded and is being performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. Shingrix is a recombinant zoster vaccine used to prevent shingles and is part of routine immunization protocols within military and federal healthcare systems. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle running through December 2026. As a child contract under this IDC, the Shingrix award leverages AmerisourceBergen's established relationship with the Defense Logistics Agency to supply critical medical commodities, including vaccines and other pharmaceutical products, to support military healthcare programs and other federal health systems worldwide. AmerisourceBergen's extensive federal procurement portfolio demonstrates its capacity to fulfill diverse medical supply requirements through competitive federal contracting processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 11/4/25 |